BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18079488)

  • 1. Usefulness of antibodies for evaluating the biological significance of AGEs.
    Nagai R; Fujiwara Y; Mera K; Motomura K; Iwao Y; Tsurushima K; Nagai M; Takeo K; Yoshitomi M; Otagiri M; Ikeda T
    Ann N Y Acad Sci; 2008 Apr; 1126():38-41. PubMed ID: 18079488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.
    Nagai R; Fujiwara Y; Mera K; Yamagata K; Sakashita N; Takeya M
    J Immunol Methods; 2008 Mar; 332(1-2):112-20. PubMed ID: 18242632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
    Koito W; Araki T; Horiuchi S; Nagai R
    J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological detection of N omega-(Carboxymethyl)arginine by a specific antibody.
    Mera K; Fujiwara Y; Otagiri M; Sakata N; Nagai R
    Ann N Y Acad Sci; 2008 Apr; 1126():155-7. PubMed ID: 18079475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products.
    Mera K; Nagai M; Brock JW; Fujiwara Y; Murata T; Maruyama T; Baynes JW; Otagiri M; Nagai R
    J Immunol Methods; 2008 May; 334(1-2):82-90. PubMed ID: 18353354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
    Choi YG; Lim S
    J Immunoassay Immunochem; 2009; 30(4):386-99. PubMed ID: 19739013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".
    Richter T; Münch G; Lüth HJ; Arendt T; Kientsch-Engel R; Stahl P; Fengler D; Kuhla B
    Neurobiol Aging; 2005 Apr; 26(4):465-74. PubMed ID: 15653175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amount of N(omega)-(Carboxymethyl)arginine generated in collagen and bovine serum albumin during glycation reactions is significantly different.
    Iijima K; Fujimoto D; Irie S
    Connect Tissue Res; 2007; 48(5):271-6. PubMed ID: 17882703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
    Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
    J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine.
    van Heijst JW; Niessen HW; Hoekman K; Schalkwijk CG
    Ann N Y Acad Sci; 2005 Jun; 1043():725-33. PubMed ID: 16037299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins.
    Nagai R; Hayashi CM; Xia L; Takeya M; Horiuchi S
    J Biol Chem; 2002 Dec; 277(50):48905-12. PubMed ID: 12377783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of N epsilon-(carboxymethyl)lysine in foods and related systems.
    Ames JM
    Ann N Y Acad Sci; 2008 Apr; 1126():20-4. PubMed ID: 18448791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues.
    Ling X; Sakashita N; Takeya M; Nagai R; Horiuchi S; Takahashi K
    Lab Invest; 1998 Dec; 78(12):1591-606. PubMed ID: 9881959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoselective synthesis of peptides containing major advanced glycation end-products of lysine and arginine.
    Gruber P; Hofmann T
    J Pept Res; 2005 Sep; 66(3):111-24. PubMed ID: 16083438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis.
    Schmitt S; Linder M; Ständker L; Hammes HP; Preissner KT
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):26-34. PubMed ID: 17926233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glucose concentration on formation of AGEs in erythrocytes in vitro.
    Nagai R; Deemer EK; Brock JW; Thorpe SR; Baynes JW
    Ann N Y Acad Sci; 2005 Jun; 1043():146-50. PubMed ID: 16037233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of N(omega)-carboxymethylarginine as a novel acid-labileadvanced glycation end product in collagen.
    Iijima K; Murata M; Takahara H; Irie S; Fujimoto D
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):23-7. PubMed ID: 10727397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of heat shock proteins and the proteasome system by casein-N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)lysine in Caco-2 cells.
    Schmid K; Haslbeck M; Buchner J; Somoza V
    Ann N Y Acad Sci; 2008 Apr; 1126():257-61. PubMed ID: 18448826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of proteins by methylglyoxal.
    Degenhardt TP; Thorpe SR; Baynes JW
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of imidazolone and N(epsilon)-(carboxymethyl)lysine in aortas of hemodialysis patients.
    Takayama F; Aoyama I; Tsukushi S; Miyazaki T; Miyazaki S; Morita T; Hirasawa Y; Shimokata K; Niwa T
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1101-9. PubMed ID: 9846892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.